dextroamphetamine has been researched along with 3-methoxytyramine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elverfors, A; Nissbrandt, H | 1 |
| Buckett, WR; Frankland, AT; Heal, DJ | 1 |
| Bonnet, JJ; Costentin, J; Vaugeois, JM | 1 |
| Carlsson, A; Pettersson, G; Svensson, K; Waters, N | 1 |
| Hashim, A; Lajtha, A; Mason, MF; Reith, ME; Sershen, H | 1 |
| Spaan, SJ; Westerink, BH | 1 |
| Kehr, W | 1 |
| Bonnet, JJ; Costentin, J; Thibaut, F; Vaugeois, JM | 2 |
| Bergquist, F; Elverfors, A; Jonason, J; Lagerkvist, S; Nissbrandt, H; Pileblad, E | 1 |
10 other study(ies) available for dextroamphetamine and 3-methoxytyramine
| Article | Year |
|---|---|
Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydrazines; Male; Organ Specificity; Rats; Rats, Wistar; Substantia Nigra; Synaptic Transmission | 1992 |
A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
Topics: alpha-Methyltyrosine; Animals; Antidepressive Agents; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Antagonists; Electrochemistry; Levodopa; Male; Methamphetamine; Methyltyrosines; Nucleus Accumbens; Pargyline; Rats; Rats, Inbred Strains; Tranylcypromine | 1990 |
Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Antagonists; Homovanillic Acid; Levodopa; Male; Mice; Motor Activity; Piperazines; Reserpine | 1990 |
The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Dextroamphetamine; Dopamine; Male; Neurotransmitter Agents; Normetanephrine; Piperazines; Psychotropic Drugs; Rats; Rats, Inbred Strains; Reserpine; Serotonin | 1989 |
Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Drug Interactions; Homovanillic Acid; Mice; Mice, Inbred BALB C; Pyridines | 1986 |
On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Benztropine; Brain; Chlorpromazine; Dextroamphetamine; Dopamine; Female; Haloperidol; Homovanillic Acid; Kinetics; Morphine; Nomifensine; Oxotremorine; Rats; Rats, Inbred Strains; Reserpine | 1982 |
3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.
Topics: 4-Butyrolactone; Animals; Apomorphine; Brain; Bromocriptine; Dextroamphetamine; Dopamine; Kinetics; Lisuride; Male; Mice; Norepinephrine; Normetanephrine; Pargyline; Receptors, Dopamine | 1981 |
In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission.
Topics: 4-Butyrolactone; Animals; Benzazepines; Cerebellum; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Agents; Levodopa; Male; Mice; Receptors, Dopamine D1 | 1996 |
Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice.
Topics: 4-Butyrolactone; Analysis of Variance; Animals; Cerebellum; Cocaine; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; GABA Modulators; Injections, Intravenous; Levodopa; Mazindol; Mice; Neostriatum; Protein Binding; Tritium | 1996 |
3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dendrites; Dextroamphetamine; Dopamine; Dopamine Agents; Drug Combinations; Extracellular Space; Homovanillic Acid; Male; Monoamine Oxidase Inhibitors; Osmolar Concentration; Pargyline; Rats; Rats, Sprague-Dawley; Reserpine; Substantia Nigra | 1997 |